Please assess the completion status of the following clinical trial:

Trial Title: Vesair Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Post-menopausal women with SUI for at least 12 months~* Average of at least one leak per day~* Failed non-invasive treatment~* Willing to undergo cystoscopy and a minimum of 5 visits over one year~Exclusion Criteria:~* BMI \> 40.0~* Last menstrual period within 12 months of enrollment~* On birth control and/or oral hormone replacement therapy~* Urge-predominant mixed incontinence~* SUI due to intrinsic sphincter deficiency~* Prior treatment with the Vesair Balloon~* Prior medical, surgical or non-surgical treatment for SUI within 6 months of enrollment~* Recurrent or recent (within the past 5 years) kidney stones~* Recurrent or recent (within the past 3 months) Urinary Tract Infection~* Stage 3 or higher cystocele (POP-Q)~* Interstitial or follicular cystitis / painful bladder syndrome~* Local genital infection~* Artificial sphincter~* Anatomic abnormalities which would interfere with device placement.~* Visible blood in the urine~* Uncontrolled bladder contractions / discomfort with bladder filling up to 300cc~* History of cancer of the urinary tract~* History of any cancer within the past two years (excluding non-melanoma skin cancers)~* History of any cancer not (yet) treated with curable intent (excluding non-melanoma skin cancers)~* Immunologically suppressed or immunocompromised~* Undergoing pelvic radiation, pelvic fibrosis from previous pelvic radiation~* Non ambulatory / unable to do simple pad weight testing exercises~* On anticoagulation therapy with the exception of aspirin~* History of mental illness requiring inpatient treatment~* Neurological disease such as Parkinson's or multiple sclerosis~* Uncontrolled diabetes (A1C \> 9%)~* Recent alcohol or drug abuse requiring treatment in the past year~* Autoimmune or connective tissue disorders such as Marfan syndrome, Ehlers-Danlos or Myasthenia Gravis~* Allergy to polyurethane or perfluorocarbons

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vesair (Type: EXPERIMENTAL): Subjects are treated with Vesair Balloon at enrollment (day 0)
- Sham (Type: SHAM_COMPARATOR): Subjects are treated with sham at enrollment (day 0) and treated with balloon (if desired) after six month visit.

Based on this trial design, predict the completion outcome and termination type (if applicable).